Ninety-one patients who had had augmentation mammaplasties were evaluated retrospectively. The intra-implant use of steroids appeared to reduce the incidence of breast firmness—at least over the short follow-up period-but there were complications from this which appear to be dose related (mg of Solu-Medrol/100 cc saline).
A long-term evaluation of such patients is desirable. Meanwhile, our limited data strongly suggest that the intra-implant use of steroids should be used only with caution as to the dose and with a careful follow-up.
©1979American Society of Plastic Surgeons